Table 3.
Groups | Relative RANKL gene expression | Relative CtsK gene expression |
---|---|---|
Gonad-intact control | 1.06 ± 0.15 | 1.03 ± 0.09 |
Osteoporotic | 1.81 ± 0.066*a (70.16%) | 1.88 ± 0.19*a (82.97%) |
nHA | 0.89 ± 0.039*b (-50.23%) | 0.55 ± 0.054*b (-70.73%) |
nCh/HA | 0.94 ± 0.04*b (-48.14%) | 0.63 ± 0.024*b (-66.36%) |
nAg/HA | 1.18 ± 0.038*b*c*d (-34.89%) | 0.67 ± 0.022*b (-64.20%) |
ALN | 1.2 ± 0.053*b*c*d (-26.67%) | 0.71 ± 0.035*b (-62.74%) |
Data are expressed as Mean ± S.E for 8 rats/group.
*a: Significant change at P < 0.05 in comparison with the gonad-intact group.
*b: Significant change at P < 0.05 in comparison with the osteoporotic group.
*c: Significant change at P < 0.05 in comparison with the nHA-treated group.
*d: Significant change at P < 0.05 in comparison with the nCh/HA-treated group.